181 related articles for article (PubMed ID: 19944256)
1. The role of prophylaxis in the management of von Willebrand disease: today and tomorrow.
Abshire T
Thromb Res; 2009 Nov; 124 Suppl 1():S15-9. PubMed ID: 19944256
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis in von Willebrand disease.
Berntorp E
Haemophilia; 2008 Nov; 14 Suppl 5():47-53. PubMed ID: 18786010
[TBL] [Abstract][Full Text] [Related]
3. Highly purified VWF/FVIII concentrates in the treatment and prophylaxis of von Willebrand disease: the PRO. WILL Study.
Federici AB
Haemophilia; 2007 Dec; 13 Suppl 5():15-24. PubMed ID: 18078393
[TBL] [Abstract][Full Text] [Related]
4. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for the evaluation of intravenous desmopressin and von Willebrand factor/factor VIII concentrate in the treatment and prophylaxis of bleedings in von Willebrand disease types 1, 2, and 3.
Michiels JJ; Gadisseur A; van der Planken M; Schroyens W; van de Velden A; Berneman Z
Semin Thromb Hemost; 2006 Sep; 32(6):636-45. PubMed ID: 16977574
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis in von Willebrand disease.
Franchini M; Targher G; Lippi G
Ann Hematol; 2007 Oct; 86(10):699-704. PubMed ID: 17634944
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis and treatment of bleeding complications in von Willebrand disease type 3.
Berntorp E
Semin Thromb Hemost; 2006 Sep; 32(6):621-5. PubMed ID: 16977572
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis and von Willebrand's disease (vWD).
Abshire TC
Thromb Res; 2006; 118 Suppl 1():S3-7. PubMed ID: 16580053
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
Budde U; Metzner HJ; Müller HG
Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of a high purity, double virus inactivated factor VIII/von Willebrand factor concentrate (Biostate) in patients with von Willebrand disorder requiring invasive or surgical procedures.
Shortt J; Dunkley S; Rickard K; Baker R; Street A
Haemophilia; 2007 Mar; 13(2):144-8. PubMed ID: 17286766
[TBL] [Abstract][Full Text] [Related]
11. Long-term prophylaxis with intermediate-purity factor VIII concentrate (Haemate P) in a patient with type 3 von Willebrand disease and recurrent gastrointestinal bleeding.
Coppola A; Cimino E; Conca P; De Simone C; Tufano A; Tarantino G; Cerbone AM; Minno G
Haemophilia; 2006 Jan; 12(1):90-4. PubMed ID: 16409182
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis in bleeding disorders.
Oldenburg J
Thromb Res; 2011 Jan; 127 Suppl 1():S14-7. PubMed ID: 21112077
[TBL] [Abstract][Full Text] [Related]
13. The von Willebrand disease prophylaxis network (vWD PN): exploring a treatment concept.
Berntorp E; Abshire T;
Thromb Res; 2006; 118 Suppl 1():S19-22. PubMed ID: 16545435
[TBL] [Abstract][Full Text] [Related]
14. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A
Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence, pathophysiology, diagnosis and treatment of von Willebrand syndrome in orthopedic trauma patients].
Kurth AA; Ludwig G; Scharrer I
Orthopade; 1999 Apr; 28(4):366-74. PubMed ID: 10335531
[TBL] [Abstract][Full Text] [Related]
16. Changes in bleeding patterns in von Willebrand disease after institution of long-term replacement therapy: results from the von Willebrand Disease Prophylaxis Network.
Holm E; Abshire TC; Bowen J; Álvarez MT; Bolton-Maggs P; Carcao M; Federici AB; Gill JC; Halimeh S; Kempton C; Key NS; Kouides P; Lail A; Landorph A; Leebeek F; Makris M; Mannucci P; Mauser-Bunschoten EP; Nugent D; Valentino LA; Winikoff R; Berntorp E
Blood Coagul Fibrinolysis; 2015 Jun; 26(4):383-8. PubMed ID: 25688461
[TBL] [Abstract][Full Text] [Related]
17. Clinical diagnosis of von Willebrand disease.
Federici AB
Haemophilia; 2004 Oct; 10 Suppl 4():169-76. PubMed ID: 15479393
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience of prophylactic treatment in von Willebrand disease.
Lethagen S
Thromb Res; 2006; 118 Suppl 1():S9-11. PubMed ID: 16616322
[TBL] [Abstract][Full Text] [Related]
19. Von Willebrand's disease: clinical management.
Federici AB; Castaman G; Thompson A; Berntorp E
Haemophilia; 2006 Jul; 12 Suppl 3():152-8. PubMed ID: 16684011
[TBL] [Abstract][Full Text] [Related]
20. von Willebrand disease update: diagnostic and treatment dilemmas.
Bolton-Maggs PH; Lillicrap D; Goudemand J; Berntorp E
Haemophilia; 2008 Jul; 14 Suppl 3():56-61. PubMed ID: 18510523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]